Louise Nott

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer

Jeanne Tie, Joshua D. Cohen, Kamel Lahouel et al. · New England Journal of Medicine · 2022 · 976 citations · Full text

Medicine, Clinical Sciences, Oncology +17

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

Harpreet Wasan, Navesh Sharma, Volker Heinemann et al. · The Lancet Oncology · 2017 · 398 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Phase III Randomized, Placebo-Controlled Study of Cetuximab Plus Brivanib Alaninate Versus Cetuximab Plus Placebo in Patients With Metastatic, Chemotherapy-Refractory, Wild-Type <i>K-RAS</i> Colorectal Carcinoma: The NCIC Clinical Trials Group and AGITG CO.20 Trial

Lillian L. Siu, Jeremy Shapiro, Derek J. Jonker et al. · Journal of Clinical Oncology · 2013 · 125 citations · Full text

Medicine, Oncology, Pharmacology +17

The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern

Thiru Prasanna, Christos S. Karapetis, David Roder et al. · Acta Oncologica · 2018 · 118 citations · Full text

Medicine, Cancer Biology, Oncology +16

Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies

Volker Heinemann, Navesh Sharma, Jens Ricke et al. · Clinical Colorectal Cancer · 2018 · 68 citations

Medicine, Oncology, Radiation Oncology +17